Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

IDO1 Antikörper

Rockland 210-301-e58 IDO1 Reaktivität: Maus WB, ELISA, IHC, IF, FACS, IP, FM, MA Wirt: Maus Monoclonal 2E2-6 unconjugated
Rockland
Produktnummer ABIN1043819
Hersteller Produkt- Nr.: 210-301-e58
  • Target Alle IDO1 Antikörper anzeigen
    IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))
    Reaktivität
    • 72
    • 31
    • 16
    • 9
    • 1
    • 1
    • 1
    Maus
    Wirt
    • 66
    • 11
    • 1
    • 1
    Maus
    Klonalität
    • 63
    • 16
    • 1
    Monoklonal
    Konjugat
    • 51
    • 5
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser IDO1 Antikörper ist unkonjugiert
    Applikation
    • 63
    • 34
    • 23
    • 17
    • 17
    • 15
    • 14
    • 8
    • 6
    • 6
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS), Immunoprecipitation (IP), Fluorescence Microscopy (FM), Multiplex Assay (MA)
    Hersteller Produkt- Nr.
    210-301-e58
    Hersteller
    Rockland
    Verwendungszweck
    IDO1 Antibody
    Kreuzreaktivität (Details)
    IDO1 antibody is specific for mouse IDO1 protein.
    Produktmerkmale
    Synonyms: mouse anti-IDO1 antibody, Ido, Indo, Indoleamine 2,3-dioxygenase 1, Indoleamine-pyrrole 2,3-dioxygenase, Ido 1, Ido-1, IDO1 antibody, mouse anti-IDO-1 antibody
    Aufreinigung
    Anti-IDO1 antibody was purified from ascites fluid by Protein A chromatography followed by extensive dialysis against the buffer stated above.
    Sterilität
    Sterile filtered
    Immunogen

    Immunogen: IDO1 antibody was produced in mouse by repeated immunizations with mouse recombinant IDO1 protein followed by hybridoma development.

    Immunogen Type: Recombinant Protein

    Klon
    2E2-6
    Isotyp
    IgG1
    Top Product
    Discover our top product IDO1 Primärantikörper
  • Applikationshinweise

    Flow Cytometry Dilution: 0.5-1x10^6 cells

    Immunohistochemistry Dilution: User Optimized

    Application Note: Anti-IDO1 antibody has been tested for use in ELISA, Western Blot, IF, IHC, and Flow Cytometry. Specific conditions for reactivity should be optimized by the end user.

    Western Blot Dilution: 1:500-1:1500

    Immunoprecipitation Dilution: 10-100 μL

    ELISA Dilution: 1:5000-1:50000

    IF Microscopy Dilution: 1:50-1:100

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.95 mg/mL
    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: None

    Preservative: 0.01 % (w/v) Sodium Azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
    Haltbarkeit
    12 months
  • Mellor, Munn: "IDO expression by dendritic cells: tolerance and tryptophan catabolism." in: Nature reviews. Immunology, Vol. 4, Issue 10, pp. 762-74, (2004) (PubMed).

  • Target
    IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))
    Andere Bezeichnung
    Ido1 (IDO1 Produkte)
    Hintergrund
    Background: Anti-IDO-1 antibody recognizes indoleamine 2, 3-dioxygenase1 (IDO1) is a 41-42 kD intracellular enzyme that catabolizes tryptophan into kynurenine. IDO1 modulates levels of the amino acid tryptophan, which is vital for cell growth, but is also involved in the suppression of the immune response. IDO1 effects on immune suppression are due to decreased tryptophan availability and the generation of tryptophan metabolites, resulting in negative effects on T lymphocytes, including proliferation, function and survival. IDO1 may be involved in the suppression of the immune response to tumors, and blocking the IDO1 pathway may be a potential target for immuno and cancer therapy. IDO1 is expressed in a wide variety of tissues and can be upregulated by interferon gamma and other inflammatory cytokines.
    Gen-ID
    15930
    NCBI Accession
    NP_032350
    UniProt
    P28776
    Pathways
    Activated T Cell Proliferation
Sie sind hier:
Kundenservice